Survey on long-term use of AJOVY for migraine treatment
AJOVY Subcutaneous Injection Long-term Specified Use-results Survey
This study is looking to see how safe AJOVY is for people using it to treat migraines over a long time, especially regarding heart-related issues.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Otsuka Pharmaceutical Co., Ltd. Industry-sponsored |
| Locations | 1 site (Osaka) |
| Trial ID | NCT05342493 on ClinicalTrials.gov |
What this trial studies
This observational study aims to evaluate the long-term safety of AJOVY, a medication for migraine disorders, in real-world settings. It will specifically assess cardiovascular events associated with its use while also collecting information on the drug's efficacy. The study will involve patients who are currently using AJOVY to gather data on its effects over time.
Who should consider this trial
Good fit: Ideal candidates for this study are patients with migraine disorders who are currently using AJOVY.
Not a fit: Patients with known hypersensitivity to components of AJOVY will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the long-term safety and effectiveness of AJOVY for migraine patients.
How similar studies have performed: Other studies evaluating long-term safety of migraine treatments have shown promising results, suggesting that this approach is relevant and potentially beneficial.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: \- Exclusion Criteria: * patients with a known hypersensitivity to components of AJOVY
Where this trial is running
Osaka
- Pharmacovigilance Department — Osaka, Japan (Recruiting)
Study contacts
- Study coordinator: Pharmacovigilance Department Otsuka Pharmaceutical Co., Ltd
- Email: komaniwa.satoshi@otsuka.jp
- Phone: +81-6-6943-7722
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.